Literature DB >> 640715

The reaction between the complement subcomponent C1q, IgG complexes and polyionic molecules.

N C Hughes-Jones, B Gardner.   

Abstract

The strength of the bond between 125I-labelled C1q and immune complexes, Fc piece, dextran sulphate, polyglutamic acid and polylysine has been investigated. The binding of C1q to Fc piece, small molecular weight (less than 10,000) dextran sulphate, polyglutamic acid and polylysine have value; for the functional affinity constant (Ko) in the range of 0.2-1.5 X 10(4) M-1. In contrast the binding of C1q to immune complexes and large molecular weight polyions (greater than 100,000 is much greater and lies in the range 3 X 10(7)--4 X 10(8) M-1. The differences in the binding constants between the two groups can be explained if the Fc piece and small molecular weight compounds bind to only 1 head of the C1q molecule but the immune complexes and large molecules bind to 2 heads. There are probably 6 binding sites on the C1q molecule for dextran sulphate. The enhancement of the binding affinity of C1q by reduction in ionic strength and the reaction with polyions, indicate that ionic groups are present near or within the binding sites.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 640715      PMCID: PMC1457604     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  8 in total

1.  Dextran sulphate--a synthetic analogue of heparin.

Authors:  C R RICKETTS
Journal:  Biochem J       Date:  1952-04       Impact factor: 3.857

2.  Fractionation of dextran and Ficoll by chromatography on Sephadex G-200.

Authors:  T C Laurent; K A Granath
Journal:  Biochim Biophys Acta       Date:  1967-03-22

3.  Inhibition of the reconstitution of the haemolytic activity of the first component of human complement by a pepsin-derived fragment of subcomponent C1q.

Authors:  K B Reid; R B Sim; A P Faiers
Journal:  Biochem J       Date:  1977-02-01       Impact factor: 3.857

4.  Antibody affinity. 3. The role of multivalance.

Authors:  C L Hornick; F Karuch
Journal:  Immunochemistry       Date:  1972-03

5.  Cooperative binding of a complement component to antigen-antibody complexes. II. Effect of variations in temperature and ionic strength.

Authors:  J J Thompson; L G Hoffmann
Journal:  Immunochemistry       Date:  1974-09

6.  Crystalline Fc prepared in high yield from normal human IgG.

Authors:  A R Sanderson; M G Lanning
Journal:  Nature       Date:  1970-04-25       Impact factor: 49.962

7.  The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cgamma2 and Cgamma3 homology regions of human immunoglobulin G1.

Authors:  D Yasmeen; J R Ellerson; K J Dorrington; R H Painter
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

8.  Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement.

Authors:  V N Schumaker; M A Calcott; H L Spiegelberg; H J Müller-Eberhard
Journal:  Biochemistry       Date:  1976-11-16       Impact factor: 3.162

  8 in total
  20 in total

Review 1.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

2.  The binding of immunoglobulin Fc to cationic proteins.

Authors:  S Pambakian; R N Poston
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

3.  DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells.

Authors:  Kinga K Hosszu; Alisa Valentino; Uma Vinayagasundaram; Rama Vinayagasundaram; M Gordon Joyce; Yan Ji; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Blood       Date:  2012-06-13       Impact factor: 22.113

4.  Inhibition of direct binding of enzyme-conjugated antihuman IgG t C1q using dextran sulphate in solid phase assays for immune complexes.

Authors:  M Gripenberg; M Rhen; A Hautanen; E Linder
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

5.  Inhibition of immune complex-mediated activation of complement. Effects of agents modulating activation of, and the activated C1 complex.

Authors:  D S Fletcher; T Y Lin
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

6.  The relationship between the binding ability and the rate of activation of the complement component C1.

Authors:  E J Folkerd; B Gardner; N C Hughes-Jones
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

7.  Complement activation by human IgG antibodies to galactose-α-1,3-galactose.

Authors:  Jens Magnus Bernth Jensen; Nick Stub Laursen; Rasmus Kjeldsen Jensen; Gregers Rom Andersen; Jens Christian Jensenius; Uffe B Skov Sørensen; Steffen Thiel
Journal:  Immunology       Date:  2020-07-14       Impact factor: 7.397

8.  Formation of complement subcomponent C1q-immunoglobulin G complex. Thermodynamic and chemical-modification studies.

Authors:  E J Emanuel; A D Brampton; D R Burton; R A Dwek
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

9.  Functional characterization of a recombinant form of the C-terminal, globular head region of the B-chain of human serum complement protein, C1q.

Authors:  U Kishore; L E Leigh; P Eggleton; P Strong; M V Perdikoulis; A C Willis; K B Reid
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

10.  Anticomplement therapy.

Authors:  Prathit A Kulkarni; Vahid Afshar-Kharghan
Journal:  Biologics       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.